We fund research into Bowel Disease.

Our vision is a world where bowel disease is eradicated.

It is a bold and ambitious vision – and deliberately so.

The patients that we serve and the researchers that we fund demand this from us.

Whilst we work towards one day meeting our vision, we will aim to develop clinical practice and improve patient’s lives through impactful research.


 

We are the subsidiary charity of the Association of Coloproctology of Great Britain and Ireland (ACPGBI) who are the representative body of leading medical practitioners working in the field of bowel disease.

The charity has been in existence since 1992 and has invested over £2.5million into research projects that have improved treatments and helped set up national guidelines for medical practice in the UK.

Many of our projects are precursors to larger scale medical research studies and thus play a crucial role in developing the necessary science and innovation to cultivate funding from the larger charities and funding organisations.

Most recently we have devised The Delphi Project which brought together surgeons, consultants, physicians and patients to establish the top 25 priority areas in bowel disease.

We are now devising research to start answering those questions to help ensure the greatest impact for patients suffering from these painful and life-limiting conditions.

 

Bowel Disease Research Foundation is an NIHR (National Institute of Health Research) non-commercial partner.

All studies funded by the charity are automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:

  • Use the NIHR Coordinated System for gaining NHS Permissions (NIHR CSP) which is accessed via the Integrated Research Application System (IRAS)
  • Access NHS support via the NIHR Clinical Research Network

BDRF is also proud members of the Association of Medical Research Charities (AMRC)

AMRC BRAND GUIDELINES DRAFT 2